Moreover, Herrera-Abreu et al. [43] found that when PI3K inhibitors are used in combination with CDK4/6 inhibitors in vitro and in PDX models of ER+ breast cancer, cells undergo apoptosis. The gene discussed is PIK3CA; the disease is breast carcinoma.